Patent · US Active

Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin II antagonist and/or a diuretic

US9993432B2 · kind B2 · utility

0Cited by

23References

26Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Alexander Kuhl · Beijing, CN
Erich Brendel · Solingen, DE
Frank Bröcker · Gevelsberg, DE
Adrian Funke · Berlin, DE
Andreas Ohm · Neuss, DE
Dennis Kvesic · Edmonton, CA
Thomas Volkmer · Berlin, DE

Key dates

Filing date	Nov 19, 2009
Grant date	Jun 12, 2018
Priority date	—
Expiry date	Nov 19, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a pharmaceutical dosage form comprising an active ingredient combination of nifedipine or nisoldipine and at least one angiotensin II antagonist and/or at least one diuretic, characterized in that nifedipine or nisoldipine is released in the body in a controlled (modified) manner and the angiotensin II antagonist and/or the diuretic is released rapidly (immediate release (IR)), and also to processes for their preparation, to their use as medicaments and to their use for the prophylaxis, secondary prophylaxis or treatment of disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.